• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Guttman, Buschner & Brooks

  • Home
  • Areas of Practice
    • High Impact Litigation
    • Whistleblower and False Claim Cases
    • Employment Litigation and Civil Rights – Employees
    • Employment Counseling and Litigation – Employers
    • Dispute Resolution and Investigation
    • Corporate Governance
  • Successes
  • Articles
  • Attorneys & Advisors
    • Justin S. Brooks
    • Traci L. Buschner
    • Judge Nancy Gertner (Ret.)
    • Dan Guttman
    • Reuben A. Guttman
    • Dr. Caroline Poplin
    • Elizabeth H. Shofner
    • Paul J. Zwier II
    • Dr. Lisa Wollman, MD
    • Rick Mountcastle
  • CLE Seminars
  • Amicus
  • Videos
  • Contact Us
    • Twitter
    • Facebook
    • LinkedIn

February 29, 2016 By Staff

Doctors promoting treatments on social media routinely fail to disclose ties to drug makers

by Sheila Kaplan (Statnews.com)

Washington – Physicians across the United States routinely offer medical advice on social media — but often fail to mention that they have accepted tens and sometimes hundreds of thousands of dollars from the companies that make the prescription drugs they tout.

A STAT examination of hundreds of social media accounts shows that health care professionals virtually never note their conflicts of interest, some of them significant, when promoting drugs or medical devices on sites such as Facebook, Instagram, and Twitter. The practice cuts across all specialties.

. . .

But Reuben Guttman, an attorney in Washington who specializes in food and drug law, said the system leaves patients vulnerable to misinformation.

“Doctors who accept these dollars and then turn around and promote on social media corrupt the market for honest medical information,” Guttman said. “And drug companies that pay these doctors are similarly poisoning the market for honest information.”

Read the full article at statnews.com.

Primary Sidebar

Information

  • Where to Start
  • Whistleblower Information
  • Federal & State False Claims Acts
  • Protecting Whistleblowers
  • CLE for Attorneys

Footer

Guttman, Buschner & Brooks PLLC

Washington DC Office NEW!
Embassy Row District
1509 22nd Street, NW
Washington, D.C. 20037
Phone: 202-800-3001

Home
Areas of Practice
Successes
Articles
Attorneys & Advisors
CLE Seminars
Amicus
Videos
Contact Us
On Demand CLE: Reuben Guttman, and Professor JC Lore present CLE covering topics in their book, Pretrial Advocacy, Wolters Kluwer-NITA (2021).”
To learn More
More about the book here
More CLEs by GBB Attorneys

Articles

How BigLaw Executive Orders May Affect Smaller Firms

Undoing An American Ideal Of Fairness

Insight: DOJ Prosecutors announce intention to drop charges against New York City Mayor Adams

More Articles

Copyright © 2025 · Guttman, Buschner & Brooks PLLC
Disclaimer